Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution.
Intra-tumor heterogeneity (ITH) is a major underlying cause of therapy resistance and disease recurrence, and is a read-out of tumor growth. Current genetic ITH analysis methods do not preserve spatial context and may not detect rare subclones. Here, we address these shortfalls by developing and val...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Nature Publishing Group
2017
|
| _version_ | 1826296000060325888 |
|---|---|
| author | Baker, A Huang, W Wang, X Jansen, M Ma, X Kim, J Anderson, C Wu, X Pan, L Su, N Luo, Y Domingo, E Heide, T Sottoriva, A Lewis, A Beggs, A Wright, N Rodriguez-Justo, M Park, E Tomlinson, I Graham, T |
| author_facet | Baker, A Huang, W Wang, X Jansen, M Ma, X Kim, J Anderson, C Wu, X Pan, L Su, N Luo, Y Domingo, E Heide, T Sottoriva, A Lewis, A Beggs, A Wright, N Rodriguez-Justo, M Park, E Tomlinson, I Graham, T |
| author_sort | Baker, A |
| collection | OXFORD |
| description | Intra-tumor heterogeneity (ITH) is a major underlying cause of therapy resistance and disease recurrence, and is a read-out of tumor growth. Current genetic ITH analysis methods do not preserve spatial context and may not detect rare subclones. Here, we address these shortfalls by developing and validating BaseScope-a novel mutation-specific RNA in situ hybridization assay. We target common point mutations in the BRAF, KRAS and PIK3CA oncogenes in archival colorectal cancer samples to precisely map the spatial and morphological context of mutant subclones. Computational modeling suggests that subclones must arise sufficiently early, or carry a considerable fitness advantage, to form large or spatially disparate subclones. Examples of putative treatment-resistant cells isolated in small topographical areas are observed. The BaseScope assay represents a significant technical advance for in situ mutation detection that provides new insight into tumor evolution, and could have ramifications for selecting patients for treatment. |
| first_indexed | 2024-03-07T04:09:37Z |
| format | Journal article |
| id | oxford-uuid:c760f0fb-770e-4d5f-a26d-16f41697dffc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:09:37Z |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:c760f0fb-770e-4d5f-a26d-16f41697dffc2022-03-27T06:44:55ZRobust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c760f0fb-770e-4d5f-a26d-16f41697dffcEnglishSymplectic Elements at OxfordNature Publishing Group2017Baker, AHuang, WWang, XJansen, MMa, XKim, JAnderson, CWu, XPan, LSu, NLuo, YDomingo, EHeide, TSottoriva, ALewis, ABeggs, AWright, NRodriguez-Justo, MPark, ETomlinson, IGraham, TIntra-tumor heterogeneity (ITH) is a major underlying cause of therapy resistance and disease recurrence, and is a read-out of tumor growth. Current genetic ITH analysis methods do not preserve spatial context and may not detect rare subclones. Here, we address these shortfalls by developing and validating BaseScope-a novel mutation-specific RNA in situ hybridization assay. We target common point mutations in the BRAF, KRAS and PIK3CA oncogenes in archival colorectal cancer samples to precisely map the spatial and morphological context of mutant subclones. Computational modeling suggests that subclones must arise sufficiently early, or carry a considerable fitness advantage, to form large or spatially disparate subclones. Examples of putative treatment-resistant cells isolated in small topographical areas are observed. The BaseScope assay represents a significant technical advance for in situ mutation detection that provides new insight into tumor evolution, and could have ramifications for selecting patients for treatment. |
| spellingShingle | Baker, A Huang, W Wang, X Jansen, M Ma, X Kim, J Anderson, C Wu, X Pan, L Su, N Luo, Y Domingo, E Heide, T Sottoriva, A Lewis, A Beggs, A Wright, N Rodriguez-Justo, M Park, E Tomlinson, I Graham, T Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution. |
| title | Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution. |
| title_full | Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution. |
| title_fullStr | Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution. |
| title_full_unstemmed | Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution. |
| title_short | Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution. |
| title_sort | robust rna based in situ mutation detection delineates colorectal cancer subclonal evolution |
| work_keys_str_mv | AT bakera robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT huangw robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT wangx robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT jansenm robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT max robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT kimj robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT andersonc robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT wux robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT panl robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT sun robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT luoy robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT domingoe robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT heidet robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT sottorivaa robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT lewisa robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT beggsa robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT wrightn robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT rodriguezjustom robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT parke robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT tomlinsoni robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution AT grahamt robustrnabasedinsitumutationdetectiondelineatescolorectalcancersubclonalevolution |